Photo: Natalia Gubernatorova
Italian-Swiss pharmaceutical company Adienne Pharma & Biotech calculates that in the near future, the Italian authorities will issue a permit for the production of the Russian Sputnik V vaccine in the country. This was stated by the president of the company Antonio Di Naro.
As Di Naro noted in an interview with RIA Novosti, he hopes to meet with the medical regulator's inspectors at the end of October 2021. At the same time, the company has already started production of experimental doses of the Russian vaccine.
According to the head of the company, his companies are already ready to produce this drug. The Russian Direct Investment Fund (RDIF) previously signed an agreement with Adienne Pharma & Biotech, which provides for the production of 10 million doses of the Russian drug Sputnik V in Italy.